NCT03306615View on ClinicalTrials.gov

Peripheral Modulation of Muscle Stiffness and Spasticity

PHASE2RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 11, 2021

Primary Completion Date

November 16, 2025

Study Completion Date

November 16, 2025

Conditions
Muscle Spasticity
Interventions
DRUG

Hyaluronidase

HYLENEX recombinant, diluted with 0.9% Sodium Chloride Injection

DRUG

Placebo

0.9% Sodium Chloride Injection

Trial Locations (1)

21231

RECRUITING

Johns Hopkins School of Medicine, Baltimore

All Listed Sponsors
collaborator

Sheikh Khalifa Stroke Institute

UNKNOWN

lead

Johns Hopkins University

OTHER